Realize that I'm the last person anyone should lis
Post# of 152098
So many different PR's could fall anytime, and it just won't be for one or two indications like in 2020 (Covid or AIDS). I know we're at the preclinical stage for many of the indications, but given the potential?
Unless you need the $ at $5.00/share, hold for more. I don't think the SP will crash again like in 2020/2021/2022 etc, we've got beachheads on too many fronts.

